Implementing A Standardized App-Led Multidisciplinary Medication Review And Reconciliation To Improve Medication Safety Before Systemic Cancer Therapy: An Ambulatory Oncology Quality Improvement Initiative,
2026
University of Kentucky
Implementing A Standardized App-Led Multidisciplinary Medication Review And Reconciliation To Improve Medication Safety Before Systemic Cancer Therapy: An Ambulatory Oncology Quality Improvement Initiative, Sarah R. Hines
DNP Projects
Background
Adult patients initiating systemic cancer therapy frequently present with pre-existing polypharmacy related to chronic comorbidities and cancer-related symptom management. The addition of anticancer therapies and supportive care medications further increases medication burden and the risk of medication-related harm. Although national organizations and institutional policies recommend comprehensive medication review before treatment initiation, implementation remains inconsistent in ambulatory oncology practice.
Purpose
To implement and evaluate a standardized Advanced Practice Provider (APP)-led multidisciplinary medication review and reconciliation process designed to identify medication medication-related safety risks before initiation of systemic cancer therapy in adult oncology patients receiving care in an ambulatory infusion center. …
Gender Differences In The Association Between Adverse Childhood Experiences And Drug Use: Findings From A Community-Based Survey In China,
2026
Macon & Joan Brock Virginia Health Sciences at Old Dominion University
Gender Differences In The Association Between Adverse Childhood Experiences And Drug Use: Findings From A Community-Based Survey In China, Hongyun Fu, Elizabeth Monk-Turner, Xiushi Yang
Department of Pediatrics Faculty Publications
Background
While adverse childhood experiences (ACEs) are widely recognized risk factors for behavioral health problems, including drug use, prior research has largely been conducted in Western countries, focused primarily on males, and relied on convenience samples without comparison groups of nonusers. Limited work has examined the impact of ACEs on drug use in non-Western contexts. This study examines gender differences in the relationship between ACEs and drug use in China, using data from a population-based probability sample survey.
Methods:
Cross-sectional data were collected in 2019 from one city in Yunnan Province in Southwest China and one city in Guangdong Province …
Pbms And Exploitation Of America's Prescription Drug System,
2026
Parkland College
Pbms And Exploitation Of America's Prescription Drug System, Ayaan Nihal Unni
A with Honors Projects
This project aims to tackle the issue of America's disproportionately expensive prescription drug system by tracking the issue to its powerful intermediaries: PBMs. I then analyze procedures both the government and the people can undertake in order to overcome this faulty system.
Clinical Outcomes With Perioperative Nivolumab By Nodal Status In Patients With Stage Iii Resectable Nsclc: Phase 3 Checkmate 77t Exploratory Analysis,
2026
The Texas Medical Center Library
Clinical Outcomes With Perioperative Nivolumab By Nodal Status In Patients With Stage Iii Resectable Nsclc: Phase 3 Checkmate 77t Exploratory Analysis, Mariano Provencio, Mark M Awad, Jonathan D Spicer, Annelies Janssens, Fedor Moiseyenko, Yang Gao, Yasutaka Watanabe, Aurelia Alexandru, Florian Guisier, Nikolaj Frost, Fabio Franke, T Jeroen Nicolaas Hiltermann, Jie He, Fumihiro Tanaka, Shun Lu, Cinthya Coronado Erdmann, Padma Sathyanarayana, Phuong Tran, Vipul Devas, Tina Cascone
Faculty, Staff and Student Publications
Individuals with non-small-cell lung cancer (NSCLC) with metastases to the ipsilateral mediastinum or subcarinal lymph nodes (N2 disease) have poor long-term survival. This exploratory analysis from the randomized phase 3 CheckMate 77T study assessed clinical outcomes by nodal status in individuals with stage III NSCLC who received neoadjuvant nivolumab plus chemotherapy followed by surgery and adjuvant nivolumab (nivolumab) versus neoadjuvant chemotherapy followed by surgery and adjuvant placebo (placebo). Here we show that among patients with N2 disease, nivolumab versus placebo improved event-free survival (1-year rate, 70% versus 45%; hazard ratio, 0.46 (95% confidence interval, 0.30–0.70)) and pathological complete response rate …
Varieties And Forms Of Capstone Experiences In U.S. Pharmacy Education,
2026
American University of Health Sciences School of Pharmacy, Signal Hill, CA 90755, USA
Varieties And Forms Of Capstone Experiences In U.S. Pharmacy Education, Mohammed A. Islam, Erfan Kohzadi, Laleh Zamirian
Health Professions Education
Purpose: In health professions education, capstone courses provide students with a culminating experience, enabling them to integrate and apply clinical and practice skills in real-world settings. With their growing adoption in Doctor of Pharmacy (PharmD) curricula, this study examined the prevalence, diversity, and structure of capstone courses across US programs. The aim was to identify emerging patterns that can inform the development of models aligned with accreditation standards, workforce expectations, and ongoing curricular improvement.
Methods: A systematic content analysis of 142 US pharmacy program websites was performed. The recorded data included course objectives, format, credit hours, course placement, teaching methods, …
Association Of Acetaminophen/Butalbital/Caffeine Doses And Incidence Of Cerebral Vasospasm,
2026
HCA Healthcare
Association Of Acetaminophen/Butalbital/Caffeine Doses And Incidence Of Cerebral Vasospasm, Emma Cloud, Mallory Stringer, Eric Shaw
South Atlantic Division GME Research Days 2026
No abstract provided.
Incidence Of Sodium Overcorrection With Acute Tolvaptan Use,
2026
HCA Healthcare
Incidence Of Sodium Overcorrection With Acute Tolvaptan Use, Emma Cloud, Alisha B. Terry
South Atlantic Division GME Research Days 2026
No abstract provided.
Burnout Amongst Pharmacy Preceptors Across The United States,
2026
HCA Healthcare
Burnout Amongst Pharmacy Preceptors Across The United States, Rachel Denison, Audrey Johnson, Danielle Croegaert, Eric Shaw
South Atlantic Division GME Research Days 2026
No abstract provided.
Evaluation Of Levetiracetam Use In Aneurysmal Subarachnoid Hemorrhage And Spontaneous Intracranial Hemorrhage For Seizure Prophylaxis,
2026
HCA Healthcare
Evaluation Of Levetiracetam Use In Aneurysmal Subarachnoid Hemorrhage And Spontaneous Intracranial Hemorrhage For Seizure Prophylaxis, Taylor Dodd, Mallory Stringer, Eric Shaw
South Atlantic Division GME Research Days 2026
No abstract provided.
Tirofiban Use Following Mechanical Thrombectomy With Emergent Stent Placement In Acute Ischemic Stroke,
2026
HCA Healthcare
Tirofiban Use Following Mechanical Thrombectomy With Emergent Stent Placement In Acute Ischemic Stroke, Taylor Dodd, Mallory Stringer, Eric Shaw
South Atlantic Division GME Research Days 2026
No abstract provided.
Evaluation Of Insulin Dosing In A Hyperkalemia Protocol,
2026
HCA Healthcare
Evaluation Of Insulin Dosing In A Hyperkalemia Protocol, Kayla Hedgspeth, Rohan Johnson, Eric Shaw, Stephanie Lesslie
South Atlantic Division GME Research Days 2026
No abstract provided.
Evaluation Of Phenobarbital Dosing For The Management Of Alcohol Withdrawal Syndrome,
2026
HCA Healthcare
Evaluation Of Phenobarbital Dosing For The Management Of Alcohol Withdrawal Syndrome, Kayla Hedgspeth, Eric Shaw, Alisha B. Terry
South Atlantic Division GME Research Days 2026
No abstract provided.
Burnout Among Pharmacy Residents,
2026
HCA Healthcare
Burnout Among Pharmacy Residents, Hunter Mcdowell, Mallory Stringer, Taja Scott, Eric Shaw
South Atlantic Division GME Research Days 2026
No abstract provided.
Comparison Of Oral Vancomycin Dosing Strategies For Initial, Non-Fulminant C. Difficile Infection Treatment,
2026
HCA Healthcare
Comparison Of Oral Vancomycin Dosing Strategies For Initial, Non-Fulminant C. Difficile Infection Treatment, Hunter Mcdowell, Eric Shaw, Danielle Lott
South Atlantic Division GME Research Days 2026
No abstract provided.
Factors Associated With Successful Publication Of Pharmacy Resident Research Projects,
2026
HCA Healthcare
Factors Associated With Successful Publication Of Pharmacy Resident Research Projects, Victoria Michel-Milian, Amy Taylor, Eric Shaw
South Atlantic Division GME Research Days 2026
No abstract provided.
Evaluating Heparin Infusions And Resultant Monitoring Parameters,
2026
HCA Healthcare
Evaluating Heparin Infusions And Resultant Monitoring Parameters, Victoria Michel-Milian, Eric Shaw, Alisha B. Terry
South Atlantic Division GME Research Days 2026
No abstract provided.
Epoetin Alfa Administration In Intermittent Hemodialysis,
2026
HCA Healthcare
Epoetin Alfa Administration In Intermittent Hemodialysis, Britany Shellhouse, Eric Shaw, Stacie Coleman
South Atlantic Division GME Research Days 2026
No abstract provided.
Evaluating The Impact Of Perioperative Antibiotic Timing On Surgical Site Infections In Hysterectomy And Colorectal Surgeries,
2026
HCA Healthcare
Evaluating The Impact Of Perioperative Antibiotic Timing On Surgical Site Infections In Hysterectomy And Colorectal Surgeries, Britany Shellhouse, Eric Shaw, Amy Taylor
South Atlantic Division GME Research Days 2026
No abstract provided.
Circulating Biomarker Results From A Phase 2 Study Of Seralutinib In Pulmonary Arterial Hypertension,
2026
Gossamer Bio, Inc., San Diego
Circulating Biomarker Results From A Phase 2 Study Of Seralutinib In Pulmonary Arterial Hypertension, Robin Osterhout, Athénaïs Boucly, Raymond L. Benza, Richard N. Channick, Kelly M. Chin, Robert P. Frantz, Anna R. Hemnes, Luke S. Howard, Vallerie V. Mclaughlin, Olivier Sitbon, Jean-Luc Vachiéry, Rotham T. Zamanian, Richard Aranda, Matt Cravets, Zhaoqing Ding, Thao Duong-Verlé, David Mattola, Robert F. Roscigno, Ravikumar Sitapara, Lawrence S. Zisman, Jean-Marie Bruey, Hossein-Ardeschir Ghofrani
Department of Medicine Faculty Publications
[Introduction] To the Editor: Pulmonary arterial hypertension (PAH) is a progressive disease characterized by obstructive pulmonary arterial remodeling (1). Seralutinib, an investigational inhaled tyrosine kinase inhibitor, potently and selectively targets kinases relevant to PAH pathobiology including platelet-derived growth factor receptors (PDGFR) α and β, colony stimulating factor 1 receptor (CSF1R), and mast/stem cell growth factor receptor kit (c-KIT) (2). In preclinical models, seralutinib improved cardiopulmonary hemodynamics, reversed pulmonary vascular pathology and decreased right ventricular hypertrophy (3). In TORREY, a phase 2, multicenter, double-blind, randomized, placebo-controlled trial in PAH, seralutinib significantly reduced pulmonary vascular resistance (PVR) after 24 weeks with good …
Investigating The Role Of Traditional Chinese Herbal Medicine For Cancer Symptom Management In Older Adults: A Rapid Review,
2026
University of Central Florida
Investigating The Role Of Traditional Chinese Herbal Medicine For Cancer Symptom Management In Older Adults: A Rapid Review, Isabelle C. Karshner
Honors Undergraduate Theses
Background: Patients with cancer often experience symptoms related to disease, complications, and treatment. One potential method of alleviating these symptoms is traditional Chinese herbal medications (TCHM). This rapid review explores the role of traditional Chinese herbal medications in treating cancer-related symptoms in older adults.
Purpose: The purpose of this rapid review is to gain and provide a better understanding of the effects of TCHM on cancer-symptom management in the older adult population. This review explores the association between TCHM and effects on cancer symptoms in older adults, including interactions, toxicity, and signs/symptoms of TCHM use that may be useful information …
